Prestige Consumer Healthcare Inc. Stock
Prestige Consumer Healthcare Inc. gained 2.680% today.
Our community is currently high on Prestige Consumer Healthcare Inc. with 4 Buy predictions and 0 Sell predictions.
As a result the target price of 61 € shows a positive potential of 32.61% compared to the current price of 46.0 € for Prestige Consumer Healthcare Inc..
Pros and Cons of Prestige Consumer Healthcare Inc. in the next few years
Pros
?
B****
?
S********** s********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prestige Consumer Healthcare Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | 2.680% | 3.653% | 10.194% | -17.455% | -15.140% | -22.393% | -10.980% |
| Apollo Medical Holdings, Inc. | -1.330% | 4.545% | -21.078% | 34.167% | 51.887% | -9.551% | -53.669% |
| Petmed Express Inc | -0.990% | -0.639% | -0.639% | -34.695% | -40.714% | -85.320% | -93.181% |
| Suzuken Co Ltd | 2.310% | -1.515% | -0.763% | 4.000% | -20.732% | 4.000% | 4.839% |
Comments
Prestige Consumer Healthcare (PBH) had its price target lowered by Canaccord Genuity Group Inc. from $86.00 to $72.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (PBH) had its price target lowered by Oppenheimer Holdings, Inc. from $77.00 to $65.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $82.00 to $72.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat